These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1026538)

  • 21. The use of disopyramide in the treatment of arrhythmias in ambulatory patients.
    Jones MB
    J Int Med Res; 1976; 4(1 Suppl):86-9. PubMed ID: 1026536
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods.
    Kimura E; Mashima S; Tanaka T
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):338-43. PubMed ID: 7409935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent use of quinidine and disopyramide: evaluation of serum concentrations and electrocardiographic effects.
    Baker BJ; Gammill J; Massengill J; Schubert E; Karin A; Doherty JE
    Am Heart J; 1983 Jan; 105(1):12-5. PubMed ID: 6849225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Indications and surveillance of quinidine and disopyramide treatments].
    Gilgenkrantz JM; Aliot E; Maureira JJ
    Rev Prat; 1975 Oct; 25(45):3485-8, 3493-4. PubMed ID: 1209116
    [No Abstract]   [Full Text] [Related]  

  • 25. Ventricular tachyarrhythmias induced by disopyramide and other similar anti-arrhythmic drugs.
    Croft CH; Kennelly BM
    S Afr Med J; 1981 Jun; 59(24):871-3. PubMed ID: 7233313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of patients at risk for sudden heart death by long-term ECG. The role of life-threatening ventricular arrhythmias].
    Hombach V; Höpp HW; Osterspey A; Winter U; Deutsch H; Hilger HH
    Herz; 1984 Feb; 9(1):6-25. PubMed ID: 6200415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dihydroquinidine versus disopyramide: efficacy in patients with chronic stable ventricular ectopy.
    Chimienti M; Panciroli C; Salerno JA; Regazzi-Bonora M; Previtali M; Cristiani D; Rondanelli R; Bobba P
    Clin Cardiol; 1984 Oct; 7(10):538-46. PubMed ID: 6386253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemodynamic effects of oral disopyramide in patients with acute myocardial infarction].
    Bassan R; Miqueloti P; de Souza MA; Luz FS
    Arq Bras Cardiol; 1982 Nov; 39(5):355-7. PubMed ID: 7186390
    [No Abstract]   [Full Text] [Related]  

  • 29. Adverse effects of disopyramide (Norpace): toxic interactions with other antiarrhythmic agents.
    Ellrodt G; Singh BN
    Heart Lung; 1980; 9(3):469-74. PubMed ID: 6901519
    [No Abstract]   [Full Text] [Related]  

  • 30. Disopyramide (Norpace) for ventricular arrhythmias.
    Med Lett Drugs Ther; 1977 Dec; 19(25):101-2. PubMed ID: 593226
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of ectopic ventricular activity with palpitin (disopyramide)].
    Penkov N; Mitkova M; Kaponov Kh; Karastatev D
    Vutr Boles; 1987; 26(2):54-7. PubMed ID: 2440188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disopyramide and quinidine.
    Rozanski JJ; Castellanos A; Sung RJ; Myerburg RJ
    N Engl J Med; 1978 Aug; 299(9):493. PubMed ID: 683296
    [No Abstract]   [Full Text] [Related]  

  • 33. [Electrophysiologic study of disopyramide].
    Ponsonnaille J; Marcheix JC; Datchary J; Gras H
    Ann Cardiol Angeiol (Paris); 1979; 28(1):49-52. PubMed ID: 434759
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral tocainide versus disopyramide: a double-blind, randomized, crossover study of outpatients with stable ventricular premature beats.
    McLaran CJ; Hossack KF; Neilson GH; Siskind V
    J Cardiovasc Pharmacol; 1984; 6(4):657-62. PubMed ID: 6206321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of the effects of disopyramide and hydroquinidine in animals].
    Lisin N; Carlier J
    Arch Mal Coeur Vaiss; 1973 Oct; 66(10):1329-35. PubMed ID: 4207476
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dynamic electrocardiography evaluation of the effectiveness of prajmalium bitartrate, disopyramide and procainamide in patients with stabilized ventricular extrasystole].
    Naccarella F; Del Corso P; Palmieri M; Cantelli I; Lentini G; Bracchetti D
    G Ital Cardiol; 1981; 11(3):338-44. PubMed ID: 6169577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac effects of disopyramide.
    Danilo P; Rosen MR
    Am Heart J; 1976 Oct; 92(4):532-6. PubMed ID: 785992
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety of multiple bolus loading of intravenous disopyramide.
    Simpson RJ; Foster JR; Benge C; Baker S; Gettes LS
    Am Heart J; 1983 Sep; 106(3):505-8. PubMed ID: 6881023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disopyramide: six years' experience.
    Wilson RR; Wallace AG
    Angiology; 1983 Jun; 34(6):367-74. PubMed ID: 6346959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison between amiodarone and disopyramide in the treatment of ventricular extrasystoles].
    Gaudeau B; Badouraly A; Herpin D; Tournadre P; Boutaud P; Amiel A; Guillem JP; Demange J
    Ann Cardiol Angeiol (Paris); 1986 Jan; 35(1):43-8. PubMed ID: 2421631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.